New hormone breast cancer treatment reduces risk of recurrence by 25%

According to research presented at the European Society for Medical Oncology's virtual conference (ESMO), a new hormonal breast cancer treatment which includes the substance abemaciclib may reduce recurrence by up to 25%.

News Medical

Subscribe to our email alerts